Clinical Cancer Research Versailles No Abst Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mateo, G.
Right arrow Articles by San Miguel, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mateo, G.
Right arrow Articles by San Miguel, J. F.
Clinical Cancer Research Vol. 11, 3661-3667, May 15, 2005
© 2005 American Association for Cancer Research


Human Cancer Biology

Genetic Abnormalities and Patterns of Antigenic Expression in Multiple Myeloma

Gema Mateo1,2, Mariana Castellanos1,2, Ana Rasillo2,3, Norma C. Gutiérrez1,2, Ma. Angeles Montalbán4, Ma. Luisa Martín4, Jesús Ma. Hernández1,2, Ma. Consuelo López-Berges1,2, Laura Montejano4, Joan Bladé6, Ma. Victoria Mateos1,2, Anna Sureda7, Javier de la Rubia5, Joaquín Díaz-Mediavilla8, Atanasio Pandiella2, Juan José Lahuerta4, Alberto Orfao2,3 and Jesús F. San Miguel1,2

Authors' Affiliations: 1 Servicio de Hematología, Hospital Universitario de Salamanca, 2 Centro de Investigación del Cáncer, Universidad de Salamanca-CSIC; 3 Servicio General de Citometría, Universidad de Salamanca; 4 Hospital 12 de Octubre; 5 Hospital Clínico Universitario, Madrid, Spain; 6 Hospital Clínic; 7 Hospital Sant Pau i Santa Creu, Barcelona, Spain; and 8 Hospital La Fe, Valencia, Spain

Requests for reprints: Jesús San Miguel Izquierdo, Servicio de Hematolog ía, Hospital Universitario de Salamanca, Paseo San Vicente 58-182, 37007 Salamanca, Spain. Phone: 34-923-291384; Fax: 34-923-294624; E-mail: sanmigiz{at}usal.es.

Myelomatous plasma cells show a high heterogeneity both in their immunophenotypic characteristics as well as in their cytogenetic features. Thus far, no extensive studies have been carried out to explore whether such antigenic diversity is associated with specific genetic characteristics. We have investigated the relationship between the immunophenotypic profile at plasma cell and both their DNA ploidy status (evaluated by flow cytometry) and specific genetic features (ascertained by fluorescence in situ hybridization) in a large series of 915 patients with newly diagnosed multiple myeloma. The non-hyperdiploid multiple myeloma group (n = 454, 52%) was associated with a significantly higher frequency of positivity for CD28 and CD20 as well as a higher incidence of CD56 and CD117 cases (P < 0.001). Remarkably, 13q deletion and immunoglobulin heavy chain (IGH) gene rearrangements, which were significantly more common in non-hyperdiploid multiple myeloma, showed a strong association with CD117 cases. IGH translocation to 11q13 was associated with reactivity for CD20 (P < 0.001), down-regulation of CD56 (P < 0.001), and lack of expression of CD117 (P = 0.001). By contrast, IGH translocations to other chromosome partners were almost exclusively found among CD20 and CD117 cases (P < 0.001). These results suggest that genetic categories in multiple myeloma exhibit particular immunophenotypic profiles which in turn are strongly associated with the DNA ploidy status.

Key Words: myeloma • immunophenotype • DNA ploidy • chromosomal abnormalities • FISH




This article has been cited by other articles:


Home page
JCOHome page
G. Mateo, M. A. Montalban, M.-B. Vidriales, J. J. Lahuerta, M. V. Mateos, N. Gutierrez, L. Rosinol, L. Montejano, J. Blade, R. Martinez, et al.
Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy
J. Clin. Oncol., June 1, 2008; 26(16): 2737 - 2744.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
A. C. Rawstron, A. Orfao, M. Beksac, L. Bezdickova, R. A. Brooimans, H. Bumbea, K. Dalva, G. Fuhler, J. Gratama, D. Hose, et al.
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
Haematologica, March 1, 2008; 93(3): 431 - 438.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. J. Chng, R. F. Schop, T. Price-Troska, I. Ghobrial, N. Kay, D. F. Jelinek, M. A. Gertz, A. Dispenzieri, M. Lacy, R. A. Kyle, et al.
Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma
Blood, October 15, 2006; 108(8): 2755 - 2763.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.